Pulse Biosciences, Inc.·4

Feb 28, 1:42 PM ET

GARDINER SANDRA A. 4

4 · Pulse Biosciences, Inc. · Filed Feb 28, 2022

Insider Transaction Report

Form 4
Period: 2021-12-14
GARDINER SANDRA
CFO & EVP Admin. and Finance
Transactions
  • Award

    Stock Option (right to buy)

    2021-12-14+25,96151,922 total
    Exercise: $13.94From: 2021-12-14Exp: 2029-11-18Common Stock (25,961 underlying)
Footnotes (2)
  • [F1]On November 18, 2019, the reporting person was granted an option to purchase 103,842 shares of the issuer's common stock. The option vests based upon the achievement of performance objectives, with vesting targets no less than 25% vesting per year upon achievement of said objectives established by the Compensation Committee of the issuer, subject to the reporting person's continued service through each vesting date. The performance objectives for 2021 were met, resulting in the vesting of the option as to 25,961 shares.
  • [F2]Represents the options which vested on the 2020 vesting date and the options which vested on the 2021 vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION